Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07392567
What this trial is testing

Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer

Who this might be right for
Colorectal Cancer Liver Metastasis
Tongji Hospital 160
Large-scale testing (Phase 3)Study completedNCT03515837
What this trial is testing

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 492
Post-approval studies (Phase 4)Ended earlyNCT00381095
What this trial is testing

Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer

Who this might be right for
Bone NeoplasmsPain, IntractableCancer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 152
Testing effectiveness (Phase 2)UnknownNCT03374839
What this trial is testing

Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients

Who this might be right for
Melanoma
Nantes University Hospital 11
Very early researchLooking for participantsNCT06008275
What this trial is testing

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

Who this might be right for
Metastatic Triple-Negative Breast CarcinomaBreast Cancer
Baylor Research Institute 20
Large-scale testing (Phase 3)Looking for participantsNCT04516681
What this trial is testing

Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerVitamin CGLUT3
Fudan University 400
Testing effectiveness (Phase 2)Study completedNCT00006019
What this trial is testing

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
LeukemiaLung CancerLymphoma+3 more
Memorial Sloan Kettering Cancer Center
Post-approval studies (Phase 4)UnknownNCT01894828
What this trial is testing

Nutritional Supplementation in Patients With no Signs of Malnutrition

Who this might be right for
Primary NeoplasmSecondary NeoplasmAbdominal Neoplasm
MedSource Polska 200
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT02542137
What this trial is testing

Abscopal Effect for Metastatic Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerRadiotherapyThymalfasin
Zhejiang Provincial People's Hospital
Not applicableEnded earlyNCT02671045
What this trial is testing

Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-small Cell Lung
Cota Inc. 649
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06842472
What this trial is testing

PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Early research (Phase 1)Looking for participantsNCT07040072
What this trial is testing

Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC

Who this might be right for
HNSCC
Beijing Tongren Hospital 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02755272
What this trial is testing

Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Carcinoma Breast Stage IV
Fox Chase Cancer Center 87
Testing effectiveness (Phase 2)Ended earlyNCT01342172
What this trial is testing

Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma

Who this might be right for
Urinary Bladder Neoplasms
Icahn School of Medicine at Mount Sinai 9
Early research (Phase 1)Looking for participantsNCT06663072
What this trial is testing

Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Pancreatic Neuroendocrine Tumor
University of Chicago 25
Testing effectiveness (Phase 2)Ended earlyNCT04683939
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Who this might be right for
Solid TumorGastric CancerGastroesophageal Junction Adenocarcinoma+5 more
BioNTech SE 13
Testing effectiveness (Phase 2)Study completedNCT00041639
What this trial is testing

Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Gilead Sciences 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT04868877
What this trial is testing

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Who this might be right for
Non-Small Cell Lung Cancer MetastaticGastric CancerEsophageal Squamous Cell Carcinoma+2 more
Merus B.V. 194
Not applicableNot Yet RecruitingNCT07112612
What this trial is testing

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
MRDProstate CancermHSPC
Anhui Medical University 50
Next Page